QCM
RGNX icon

Quantinno Capital Management’s Regenxbio RGNX Stock Holding History

Quantinno Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.6M Buy
300,127
+256,176
+583% +$2.13M ﹤0.01% 1503
2026
Q1 		$368K Sell
43,951
-6,042
-12% -$63.5K ﹤0.01% 2920
2025
Q4 		$720K Buy
49,993
+22,647
+83% +$282K ﹤0.01% 2059
2025
Q3 		$264K Buy
27,346
+7,338
+37% +$64.9K ﹤0.01% 2562
2025
Q2 		$164K Sell
20,008
-685
-3% -$5.73K ﹤0.01% 2411
2025
Q1 		$148K Buy
+20,693
New +$154K ﹤0.01% 1948

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Quantinno Capital Management's RGNX Position: Q2 2026 in Review

Quantinno Capital Management increased its Regenxbio (RGNX) stake by 583% in Q2 2026, buying an estimated $2.13M and bringing the position to 300,127 shares worth $3.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1503.

Quantinno Capital Management first reported a position in RGNX in Q1 2025 and has held it in 6 quarters since. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Quantinno Capital Management held 300,127 shares of Regenxbio worth $3.6M as of Q2 2026.
  • Quantinno Capital Management bought 256,176 Regenxbio shares in Q2 2026, an estimated $2.13M.
  • Regenxbio made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1503 holding.
  • Quantinno Capital Management first reported a position in Regenxbio in Q1 2025 and has held it in 6 quarters since.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.